murine shrna Search Results


90
SuperArray Bioscience Corporation suresilencing shrna and scrambled control plasmids for murine abca1
Suresilencing Shrna And Scrambled Control Plasmids For Murine Abca1, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+shrna/suresilencing+shrna+and+scrambled+control+plasmids+for+murine+abca1/10__1172_slash_jci32057-164-7-12
Average 90 stars, based on 1 article reviews
suresilencing shrna and scrambled control plasmids for murine abca1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Broad Institute Inc lentiviral shrna constructs targeting murine cyld and gfp
Lentiviral Shrna Constructs Targeting Murine Cyld And Gfp, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+shrna/lentiviral+shrna+constructs+targeting+murine+cyld+and+gfp/pmc02746958-303-7-16
Average 90 stars, based on 1 article reviews
lentiviral shrna constructs targeting murine cyld and gfp - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma shrna targeting murine calr
Shrna Targeting Murine Calr, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+shrna/shrna+targeting+murine+calr/pm33893275-283-6-38
Average 90 stars, based on 1 article reviews
shrna targeting murine calr - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Welgen Inc recombinant adenovirus expressing small hairpin rna (shrna) for murine hsl
Recombinant Adenovirus Expressing Small Hairpin Rna (Shrna) For Murine Hsl, supplied by Welgen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+shrna/recombinant+adenovirus+expressing+small+hairpin+rna++shrna++for+murine+hsl/pm16595669-83-8-21
Average 90 stars, based on 1 article reviews
recombinant adenovirus expressing small hairpin rna (shrna) for murine hsl - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Welgen Inc adenoviral vectors expressing a short hairpin sequence targeted against nrf2 (shnrf2) or a non-targeting sequence (shctr)
Cardiac-specific activation of <t>NRF2</t> induces metabolic reprogramming in the heart. A ) mRNA levels of Keap1 and NRF2 targets B ) glutathione-S-transferase α2 ( Gsta2 ), C ) glutathione-disulphide reductase ( Gsr ), D ) nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1 (Nqo1) in the hearts of csKeap1KO and WT control mice. n ≥ 3/group. E ) Principal component analysis of targeted metabolomic profile of csKeap1KO vs. WT hearts, n ≥ 4/group. F ) Heat map showing hierarchical clustering of metabolite abundance for the top 60 features in WT vs. csKeap1KO hearts. Data are presented as mean ± SEM. ** P < 0.01, *** P < 0.001, **** P < 0.0001 and ns, not significant by unpaired Student’s t -test.
Adenoviral Vectors Expressing A Short Hairpin Sequence Targeted Against Nrf2 (Shnrf2) Or A Non Targeting Sequence (Shctr), supplied by Welgen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+shrna/adenovirus+of+gfp++murine+nrf2++scramble+shrna++or+rat+nrf2+shrna/pmc12012450-97-17-6
Average 90 stars, based on 1 article reviews
adenoviral vectors expressing a short hairpin sequence targeted against nrf2 (shnrf2) or a non-targeting sequence (shctr) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Becton Dickinson shrna oligonucleotides were derived from the murine gro-a sequence (nih genbank accession no. j04596)
Cardiac-specific activation of <t>NRF2</t> induces metabolic reprogramming in the heart. A ) mRNA levels of Keap1 and NRF2 targets B ) glutathione-S-transferase α2 ( Gsta2 ), C ) glutathione-disulphide reductase ( Gsr ), D ) nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1 (Nqo1) in the hearts of csKeap1KO and WT control mice. n ≥ 3/group. E ) Principal component analysis of targeted metabolomic profile of csKeap1KO vs. WT hearts, n ≥ 4/group. F ) Heat map showing hierarchical clustering of metabolite abundance for the top 60 features in WT vs. csKeap1KO hearts. Data are presented as mean ± SEM. ** P < 0.01, *** P < 0.001, **** P < 0.0001 and ns, not significant by unpaired Student’s t -test.
Shrna Oligonucleotides Were Derived From The Murine Gro A Sequence (Nih Genbank Accession No. J04596), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+shrna/shrna+oligonucleotides+were+derived+from+the+murine+gro+a+sequence++nih+genbank+accession+no++j04596+/pm16618733-99-35-53
Average 90 stars, based on 1 article reviews
shrna oligonucleotides were derived from the murine gro-a sequence (nih genbank accession no. j04596) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Schattauer GmbH shrna against murine larg
Cardiac-specific activation of <t>NRF2</t> induces metabolic reprogramming in the heart. A ) mRNA levels of Keap1 and NRF2 targets B ) glutathione-S-transferase α2 ( Gsta2 ), C ) glutathione-disulphide reductase ( Gsr ), D ) nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1 (Nqo1) in the hearts of csKeap1KO and WT control mice. n ≥ 3/group. E ) Principal component analysis of targeted metabolomic profile of csKeap1KO vs. WT hearts, n ≥ 4/group. F ) Heat map showing hierarchical clustering of metabolite abundance for the top 60 features in WT vs. csKeap1KO hearts. Data are presented as mean ± SEM. ** P < 0.01, *** P < 0.001, **** P < 0.0001 and ns, not significant by unpaired Student’s t -test.
Shrna Against Murine Larg, supplied by Schattauer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+shrna/shrna+against+murine+larg/10__1160_slash_th15___11___0848-135-19-12
Average 90 stars, based on 1 article reviews
shrna against murine larg - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma lentivirus vectors expressing control shrna and specific shrna against human rgcc and murine rgcc
Cardiac-specific activation of <t>NRF2</t> induces metabolic reprogramming in the heart. A ) mRNA levels of Keap1 and NRF2 targets B ) glutathione-S-transferase α2 ( Gsta2 ), C ) glutathione-disulphide reductase ( Gsr ), D ) nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1 (Nqo1) in the hearts of csKeap1KO and WT control mice. n ≥ 3/group. E ) Principal component analysis of targeted metabolomic profile of csKeap1KO vs. WT hearts, n ≥ 4/group. F ) Heat map showing hierarchical clustering of metabolite abundance for the top 60 features in WT vs. csKeap1KO hearts. Data are presented as mean ± SEM. ** P < 0.01, *** P < 0.001, **** P < 0.0001 and ns, not significant by unpaired Student’s t -test.
Lentivirus Vectors Expressing Control Shrna And Specific Shrna Against Human Rgcc And Murine Rgcc, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+shrna/lentivirus+vectors+expressing+control+shrna+and+specific+shrna+against+human+rgcc+and+murine+rgcc/pm38102722-110-13-18
Average 90 stars, based on 1 article reviews
lentivirus vectors expressing control shrna and specific shrna against human rgcc and murine rgcc - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
GenScript corporation shrna targeting the murine ccl9
Cardiac-specific activation of <t>NRF2</t> induces metabolic reprogramming in the heart. A ) mRNA levels of Keap1 and NRF2 targets B ) glutathione-S-transferase α2 ( Gsta2 ), C ) glutathione-disulphide reductase ( Gsr ), D ) nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1 (Nqo1) in the hearts of csKeap1KO and WT control mice. n ≥ 3/group. E ) Principal component analysis of targeted metabolomic profile of csKeap1KO vs. WT hearts, n ≥ 4/group. F ) Heat map showing hierarchical clustering of metabolite abundance for the top 60 features in WT vs. csKeap1KO hearts. Data are presented as mean ± SEM. ** P < 0.01, *** P < 0.001, **** P < 0.0001 and ns, not significant by unpaired Student’s t -test.
Shrna Targeting The Murine Ccl9, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+shrna/shrna+targeting+the+murine+ccl9/pm40461158-63-0-8
Average 90 stars, based on 1 article reviews
shrna targeting the murine ccl9 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
EZBiolab Inc shrnas against murine lrp1 in a lentivirus
Cardiac-specific activation of <t>NRF2</t> induces metabolic reprogramming in the heart. A ) mRNA levels of Keap1 and NRF2 targets B ) glutathione-S-transferase α2 ( Gsta2 ), C ) glutathione-disulphide reductase ( Gsr ), D ) nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1 (Nqo1) in the hearts of csKeap1KO and WT control mice. n ≥ 3/group. E ) Principal component analysis of targeted metabolomic profile of csKeap1KO vs. WT hearts, n ≥ 4/group. F ) Heat map showing hierarchical clustering of metabolite abundance for the top 60 features in WT vs. csKeap1KO hearts. Data are presented as mean ± SEM. ** P < 0.01, *** P < 0.001, **** P < 0.0001 and ns, not significant by unpaired Student’s t -test.
Shrnas Against Murine Lrp1 In A Lentivirus, supplied by EZBiolab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+shrna/shrnas+against+murine+lrp1+in+a+lentivirus/pmc02745847-95-19-21
Average 90 stars, based on 1 article reviews
shrnas against murine lrp1 in a lentivirus - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
TaconicArtemis gmbh shrna-mediated knockdown murine model
Cardiac-specific activation of <t>NRF2</t> induces metabolic reprogramming in the heart. A ) mRNA levels of Keap1 and NRF2 targets B ) glutathione-S-transferase α2 ( Gsta2 ), C ) glutathione-disulphide reductase ( Gsr ), D ) nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1 (Nqo1) in the hearts of csKeap1KO and WT control mice. n ≥ 3/group. E ) Principal component analysis of targeted metabolomic profile of csKeap1KO vs. WT hearts, n ≥ 4/group. F ) Heat map showing hierarchical clustering of metabolite abundance for the top 60 features in WT vs. csKeap1KO hearts. Data are presented as mean ± SEM. ** P < 0.01, *** P < 0.001, **** P < 0.0001 and ns, not significant by unpaired Student’s t -test.
Shrna Mediated Knockdown Murine Model, supplied by TaconicArtemis gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+shrna/shrna+mediated+knockdown+murine+model/pmc03166794-121-6-15
Average 90 stars, based on 1 article reviews
shrna-mediated knockdown murine model - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
SuperArray Bioscience Corporation murine lck shrnas
Cardiac-specific activation of <t>NRF2</t> induces metabolic reprogramming in the heart. A ) mRNA levels of Keap1 and NRF2 targets B ) glutathione-S-transferase α2 ( Gsta2 ), C ) glutathione-disulphide reductase ( Gsr ), D ) nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1 (Nqo1) in the hearts of csKeap1KO and WT control mice. n ≥ 3/group. E ) Principal component analysis of targeted metabolomic profile of csKeap1KO vs. WT hearts, n ≥ 4/group. F ) Heat map showing hierarchical clustering of metabolite abundance for the top 60 features in WT vs. csKeap1KO hearts. Data are presented as mean ± SEM. ** P < 0.01, *** P < 0.001, **** P < 0.0001 and ns, not significant by unpaired Student’s t -test.
Murine Lck Shrnas, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/murine+shrna/murine+lck+shrnas/pmc02867266-65-0-14
Average 90 stars, based on 1 article reviews
murine lck shrnas - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Cardiac-specific activation of NRF2 induces metabolic reprogramming in the heart. A ) mRNA levels of Keap1 and NRF2 targets B ) glutathione-S-transferase α2 ( Gsta2 ), C ) glutathione-disulphide reductase ( Gsr ), D ) nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1 (Nqo1) in the hearts of csKeap1KO and WT control mice. n ≥ 3/group. E ) Principal component analysis of targeted metabolomic profile of csKeap1KO vs. WT hearts, n ≥ 4/group. F ) Heat map showing hierarchical clustering of metabolite abundance for the top 60 features in WT vs. csKeap1KO hearts. Data are presented as mean ± SEM. ** P < 0.01, *** P < 0.001, **** P < 0.0001 and ns, not significant by unpaired Student’s t -test.

Journal: Cardiovascular Research

Article Title: NRF2 activation in the heart induces glucose metabolic reprogramming and reduces cardiac dysfunction via upregulation of the pentose phosphate pathway

doi: 10.1093/cvr/cvae250

Figure Lengend Snippet: Cardiac-specific activation of NRF2 induces metabolic reprogramming in the heart. A ) mRNA levels of Keap1 and NRF2 targets B ) glutathione-S-transferase α2 ( Gsta2 ), C ) glutathione-disulphide reductase ( Gsr ), D ) nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1 (Nqo1) in the hearts of csKeap1KO and WT control mice. n ≥ 3/group. E ) Principal component analysis of targeted metabolomic profile of csKeap1KO vs. WT hearts, n ≥ 4/group. F ) Heat map showing hierarchical clustering of metabolite abundance for the top 60 features in WT vs. csKeap1KO hearts. Data are presented as mean ± SEM. ** P < 0.01, *** P < 0.001, **** P < 0.0001 and ns, not significant by unpaired Student’s t -test.

Article Snippet: Cells were transduced with adenoviral vectors (Welgen Inc., Worcester, MA) expressing a short hairpin sequence targeted against NRF2 (shNRF2) or a non-targeting sequence (shCtr) at MOI 500.

Techniques: Activation Assay, Control

Effect of constitutive activation of NRF2 in the heart on 13 C enrichment of metabolites after ex vivo Langendorff perfusion of [U- 13 C]glucose. A ) Schematic representation of [U- 13 C]glucose carbon labelling through glycolysis, PPP, and TCA cycle (filled circles indicate 13 C-labelled carbons, and empty circles indicate 12 C carbons). B ) 13 C-glucose incorporation into upper glycolytic metabolites: G6P and F6P (mass isotopologue distribution, M.I.D.), C ) 13 C-glucose incorporation into PPP metabolites: R5P and S7P (M.I.D.), D ) 13 C-glucose incorporation into lower glycolytic metabolites: 2/3PG and lactate (M.I.D.), E ) 13 C-glucose incorporation into TCA cycle metabolites: citrate, alpha-ketoglutarate, malate, and fumarate (M.I.D.) in WT vs. csKeap1KO heart following ex vivo Langendorff perfusion of [U- 13 C]glucose, n = 3/group. Mass isotopologue distribution refers to the relative abundance (in percentage) of isotopically labelled molecules with different masses within a given metabolite. m + 0, refers to unlabelled isotopologue, m + 1 to isotopologues containing one 13 C atom, m + 2 to isotopologues with two 13 C atoms, etc. Data are presented as mean ± SEM. * P < 0.05, *** P < 0.001, **** P < 0.0001 and ns, not significant by one-way ANOVA followed by Bonferroni multiple comparison test for mass isotopologue comparisons.

Journal: Cardiovascular Research

Article Title: NRF2 activation in the heart induces glucose metabolic reprogramming and reduces cardiac dysfunction via upregulation of the pentose phosphate pathway

doi: 10.1093/cvr/cvae250

Figure Lengend Snippet: Effect of constitutive activation of NRF2 in the heart on 13 C enrichment of metabolites after ex vivo Langendorff perfusion of [U- 13 C]glucose. A ) Schematic representation of [U- 13 C]glucose carbon labelling through glycolysis, PPP, and TCA cycle (filled circles indicate 13 C-labelled carbons, and empty circles indicate 12 C carbons). B ) 13 C-glucose incorporation into upper glycolytic metabolites: G6P and F6P (mass isotopologue distribution, M.I.D.), C ) 13 C-glucose incorporation into PPP metabolites: R5P and S7P (M.I.D.), D ) 13 C-glucose incorporation into lower glycolytic metabolites: 2/3PG and lactate (M.I.D.), E ) 13 C-glucose incorporation into TCA cycle metabolites: citrate, alpha-ketoglutarate, malate, and fumarate (M.I.D.) in WT vs. csKeap1KO heart following ex vivo Langendorff perfusion of [U- 13 C]glucose, n = 3/group. Mass isotopologue distribution refers to the relative abundance (in percentage) of isotopically labelled molecules with different masses within a given metabolite. m + 0, refers to unlabelled isotopologue, m + 1 to isotopologues containing one 13 C atom, m + 2 to isotopologues with two 13 C atoms, etc. Data are presented as mean ± SEM. * P < 0.05, *** P < 0.001, **** P < 0.0001 and ns, not significant by one-way ANOVA followed by Bonferroni multiple comparison test for mass isotopologue comparisons.

Article Snippet: Cells were transduced with adenoviral vectors (Welgen Inc., Worcester, MA) expressing a short hairpin sequence targeted against NRF2 (shNRF2) or a non-targeting sequence (shCtr) at MOI 500.

Techniques: Activation Assay, Ex Vivo, Comparison

NRF2-mediated upregulation of the PPP prevents stress-induced cardiomyocyte death. A ) mRNA levels of Keap1 , G6pd , Pgd , and Tkt measured in NRVMs transfected with either control scrambled siRNA or siKeap1. n ≥ 5/group. B ) Schematic representation of glycolysis and PPP highlighting the PPP enzymes (G6PD and PGD) inhibited by 6-AN. C ) Cell viability measured as the percentage of 7AAD-positive over Hoechst-positive cells (7AAD + /Hoechst + ) in NRVM transfected with siScrambled or siKeap1, untreated or treated for 24 h with different combinations of isoproterenol and/or 6-AN. Four independent experiments, n ≥ 550 cells/group. D ) Representative immunoblot showing efficient knockdown of G6PD in NRVM transfected with siG6pd alone or in combination with siKeap1. Tubulin was used as a loading marker. E ) Percentage of 7AAD + /Hoechst + calculated in NRVMs transfected with siScrambled or siKeap1 and with or without siG6pd, and treated as indicated; n = 4, ≥600 cells. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001 and **** P < 0.0001 and ns, not significant by unpaired Student’s t -test or by two-way ANOVA, followed by Tukey’s multiple comparisons test.

Journal: Cardiovascular Research

Article Title: NRF2 activation in the heart induces glucose metabolic reprogramming and reduces cardiac dysfunction via upregulation of the pentose phosphate pathway

doi: 10.1093/cvr/cvae250

Figure Lengend Snippet: NRF2-mediated upregulation of the PPP prevents stress-induced cardiomyocyte death. A ) mRNA levels of Keap1 , G6pd , Pgd , and Tkt measured in NRVMs transfected with either control scrambled siRNA or siKeap1. n ≥ 5/group. B ) Schematic representation of glycolysis and PPP highlighting the PPP enzymes (G6PD and PGD) inhibited by 6-AN. C ) Cell viability measured as the percentage of 7AAD-positive over Hoechst-positive cells (7AAD + /Hoechst + ) in NRVM transfected with siScrambled or siKeap1, untreated or treated for 24 h with different combinations of isoproterenol and/or 6-AN. Four independent experiments, n ≥ 550 cells/group. D ) Representative immunoblot showing efficient knockdown of G6PD in NRVM transfected with siG6pd alone or in combination with siKeap1. Tubulin was used as a loading marker. E ) Percentage of 7AAD + /Hoechst + calculated in NRVMs transfected with siScrambled or siKeap1 and with or without siG6pd, and treated as indicated; n = 4, ≥600 cells. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001 and **** P < 0.0001 and ns, not significant by unpaired Student’s t -test or by two-way ANOVA, followed by Tukey’s multiple comparisons test.

Article Snippet: Cells were transduced with adenoviral vectors (Welgen Inc., Worcester, MA) expressing a short hairpin sequence targeted against NRF2 (shNRF2) or a non-targeting sequence (shCtr) at MOI 500.

Techniques: Transfection, Control, Western Blot, Knockdown, Marker

Stress-induced cardiomyocyte DNA damage is limited by NRF2 and the PPP. A ) mRNA levels of G6pd, and B ) Pgd in NRVM transduced with adenovirus expressing either control scrambled shRNA or siNrf2 and untreated or treated with isoproterenol. n = 5/group. C ) Quantification of cell viability measured as the percentage of 7AAD + /Hoechst + cells. Four independent experiments, n ≥ 500 cells/group. D ) Representative immunofluorescence images of NRVM transduced with adenovirus expressing control shRNA or shNRF2 untreated or treated with 100 µmol/L isoproterenol for 8 h. Cells were stained with antibodies for α-actinin, γ-H2A.X, and DAPI. Scale bar: 10 µm. E ) Percentage of γ-H2A.X positive cells were divided into three groups depending on the number of γ-H2A.X foci per nucleus: low DNA damage (0–5 foci/nucleus), moderate DNA damage (5–15 foci/nucleus) and high DNA damage (>15 foci/nucleus). NRVM were infected with adenovirus expressing control shRNA or shNRF2, untreated or treated with isoproterenol for 8 h. Four independent biological replicates, n ≥ 50 cells per condition. F ) Representative confocal images of NRVM infected with adenovirus expressing shNRF2 and untreated or treated for 8 h with isoproterenol alone or in combinations with nucleosides or NADPH. Cells were stained with antibodies for α-actinin, γ-H2A.X and DAPI. Scale bar: 10 µm. G ) Summary and quantification of the percentage of cells with more than five γ-H2A.X positive foci/nucleus. NRVM were infected, treated, and stained as described in ( E ). Three to four biological replicates, n ≥ 40 cells/group. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01 and ns, not significant by one-way ANOVA, followed by Tukey’s multiple comparisons test.

Journal: Cardiovascular Research

Article Title: NRF2 activation in the heart induces glucose metabolic reprogramming and reduces cardiac dysfunction via upregulation of the pentose phosphate pathway

doi: 10.1093/cvr/cvae250

Figure Lengend Snippet: Stress-induced cardiomyocyte DNA damage is limited by NRF2 and the PPP. A ) mRNA levels of G6pd, and B ) Pgd in NRVM transduced with adenovirus expressing either control scrambled shRNA or siNrf2 and untreated or treated with isoproterenol. n = 5/group. C ) Quantification of cell viability measured as the percentage of 7AAD + /Hoechst + cells. Four independent experiments, n ≥ 500 cells/group. D ) Representative immunofluorescence images of NRVM transduced with adenovirus expressing control shRNA or shNRF2 untreated or treated with 100 µmol/L isoproterenol for 8 h. Cells were stained with antibodies for α-actinin, γ-H2A.X, and DAPI. Scale bar: 10 µm. E ) Percentage of γ-H2A.X positive cells were divided into three groups depending on the number of γ-H2A.X foci per nucleus: low DNA damage (0–5 foci/nucleus), moderate DNA damage (5–15 foci/nucleus) and high DNA damage (>15 foci/nucleus). NRVM were infected with adenovirus expressing control shRNA or shNRF2, untreated or treated with isoproterenol for 8 h. Four independent biological replicates, n ≥ 50 cells per condition. F ) Representative confocal images of NRVM infected with adenovirus expressing shNRF2 and untreated or treated for 8 h with isoproterenol alone or in combinations with nucleosides or NADPH. Cells were stained with antibodies for α-actinin, γ-H2A.X and DAPI. Scale bar: 10 µm. G ) Summary and quantification of the percentage of cells with more than five γ-H2A.X positive foci/nucleus. NRVM were infected, treated, and stained as described in ( E ). Three to four biological replicates, n ≥ 40 cells/group. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01 and ns, not significant by one-way ANOVA, followed by Tukey’s multiple comparisons test.

Article Snippet: Cells were transduced with adenoviral vectors (Welgen Inc., Worcester, MA) expressing a short hairpin sequence targeted against NRF2 (shNRF2) or a non-targeting sequence (shCtr) at MOI 500.

Techniques: Transduction, Expressing, Control, shRNA, Immunofluorescence, Staining, Infection